SpringWorks Therapeutics Inc [NASDAQ: SWTX] surged by $3.72 during the normal trading session on while it closed the day at $44.93.
SpringWorks Therapeutics Inc stock has also gained 19.05% of its value over the past 7 days. However, SWTX stock has inclined by 24.32% in the 3 months of the year. Over the past six months meanwhile, it has gained 47.36% and gained 24.36% year-on date.
The market cap for SWTX stock reached $3.37 billion, with 74.40 million shares outstanding and 70.37 million shares in the current float. Compared to the average trading volume of 2.56M shares, SWTX reached a trading volume of 8810165 in the most recent trading day, which is why market watchdogs consider the stock to be active.
Here’s what leading stock market gurus have to say about SpringWorks Therapeutics Inc [SWTX]:
Based on careful and fact-backed analyses by Wall Street experts, the current consensus on the target price for SWTX shares is $70.86 per share. Analysis on target price and performance of stocks is usually carefully studied by market experts, and the current Wall Street consensus on SWTX stock is a recommendation set at 1.14. This rating represents a strong Buy recommendation, on the scale from 1 to 5, where 5 would mean strong sell, 4 represents Sell, 3 is Hold, and 2 indicates Buy.
Evercore ISI have made an estimate for SpringWorks Therapeutics Inc shares, keeping their opinion on the stock as Outperform, with their previous recommendation back on November 20, 2024. While these analysts kept the previous recommendation, Guggenheim raised their target price to Buy. The new note on the price target was released on February 05, 2024, representing the official price target for SpringWorks Therapeutics Inc stock. Previously, the target price had yet another raise to $45, while BofA Securities analysts kept a Buy rating on SWTX stock. On January 19, 2021, analysts increased their price target for SWTX shares from 87 to 101.
The Average True Range (ATR) for SpringWorks Therapeutics Inc is set at 3.05, with the Price to Sales ratio for SWTX stock in the period of the last 12 months amounting to 17.58. The Price to Book ratio for the last quarter was 6.95, with the Price to Cash per share for the same quarter was set at 4.11.
SWTX stock trade performance evaluation
SpringWorks Therapeutics Inc [SWTX] gain into the green zone at the end of the last week, gaining into a positive trend and gaining by 19.05. With this latest performance, SWTX shares dropped by -4.83% in over the last four-week period, additionally plugging by 47.36% over the last 6 months – not to mention a rise of 4.76% in the past year of trading.
Overbought and oversold stocks can be easily traced with the Relative Strength Index (RSI), where an RSI result of over 70 would be overbought, and any rate below 30 would indicate oversold conditions. An RSI rate of 50 would represent a neutral market momentum. The current RSI for SWTX stock in for the last two-week period is set at 56.56, with the RSI for the last a single of trading hit 65.37, and the three-weeks RSI is set at 52.95 for SpringWorks Therapeutics Inc [SWTX]. The present Moving Average for the last 50 days of trading for this stock 47.72, while it was recorded at 40.32 for the last single week of trading, and 39.33 for the last 200 days.
SpringWorks Therapeutics Inc [SWTX]: An insightful look at the core fundamentals
SpringWorks Therapeutics Inc’s liquidity data is similarly interesting compelling, with a Quick Ratio of 3.70 and a Current Ratio set at 3.81.
SpringWorks Therapeutics Inc [SWTX]: Institutional Ownership
There are presently around $112.57%, or 114.02%% of SWTX stock, in the hands of institutional investors. The top three institutional holders of SWTX stocks are: FMR LLC with ownership of 11.11 million shares, which is approximately 14.9922%. VANGUARD GROUP INC, holding 6.54 million shares of the stock with an approximate value of $$246.53 million in SWTX stocks shares; and VANGUARD GROUP INC, currently with $$211.68 million in SWTX stock with ownership which is approximately 7.5812%.
